Skip to main content
Caplight Logo









Optimale

Optimale

Private
LondonHealthcare & Life Scienceshttps://optimale.co.uk/

Last Round

Angel

Sep 11, 2025

Total Funding Raised

$194M

Company Overview

Optimale is a healthcare company that provides medical services, diagnostics, and testosterone replacement therapy (TRT) to patients in the United Kingdom.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, D2C Brands, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

telehealthtestosterone replacement therapyTRTmen's healthhormone optimizationlow testosteroneTRT clinicblood testingdiagnostic pathologyremote consultationsubscription healthcarehormonal healthdirect-to-consumer healthcareD2C telehealthonline TRT clinic

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Optimale Comparables

Compare Optimale with similar companies based on industry and business-model similarity.

Optimale comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Alphagenix Ltd
94%
Balance My Hormones Ltd
94%
Ted's Health
91%

Optimale Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelSep 11, 2025
DebtNov 1, 2024
Series BSep 15, 2024
Series AMar 30, 2021
SeedJan 15, 2019

Key People

Founding team and executive leadership

David Kennett

COO, Co-Founder

Founding Team

Optimale Investors

Notable investors and investment history

Optimale investors
InvestorRounds
CASSIUSSeed
WaldencastSeries A
Felix CapitalSeed, Series B, Series A
FJ LabsSeries A
Sonoma Brands CapitalSeries A
Octopus VenturesSeries B
Cherry VenturesSeed, Series B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2025

    Raised an Angel round with participation from James Smith.

  • Sep 15, 2024

    $38M round led by Cherry Ventures, Felix Capital, and Octopus Ventures.

Optimale Filings

Explore SEC and related filing metadata, where available.

Optimale filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Optimale's valuation, stock price, and market status.

Is Optimale a public or private company?

Optimale is a private company.

What is the current stock price of Optimale?

Optimale is a private company with no public stock price. Caplight tracks Optimale's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Optimale worth (valuation)?

Valuation information for Optimale is not publicly available.

Can I buy Optimale stock?

Optimale shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Optimale's last funding round?

Optimale's most recent funding round was Angel on September 11, 2025.

Who are the main investors in Optimale?

Key investors in Optimale include CASSIUS, Waldencast, Felix Capital, FJ Labs, Sonoma Brands Capital.

Will Optimale IPO soon?

No public IPO plans have been announced for Optimale.

How can I track Optimale secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Optimale's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range12
Year Founded2017
Last FundingSep 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?